skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma

BMC cancer, 2022-05, Vol.22 (1), p.592-592, Article 592 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09692-0 ;PMID: 35637429

Full text available

Citations Cited by
  • Title:
    Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
  • Author: Ma, Heng ; Feng, Peng-Hui ; Yu, Shuang-Ni ; Lu, Zhao-Hui ; Yu, Qi ; Chen, Jie
  • Subjects: Cancer ; Prognosis
  • Is Part Of: BMC cancer, 2022-05, Vol.22 (1), p.592-592, Article 592
  • Publisher: England: BioMed Central Ltd
  • Language: English
  • Identifier: ISSN: 1471-2407
    EISSN: 1471-2407
    DOI: 10.1186/s12885-022-09692-0
    PMID: 35637429
  • Source: PubMed (Medline)
    AUTh Library subscriptions: ProQuest Central
    GFMER Free Medical Journals
    ROAD: Directory of Open Access Scholarly Resources
    DOAJ Directory of Open Access Journals
    Springer Nature OA Free Journals

Searching Remote Databases, Please Wait